Delivery Order SPE2DB20D9354-SPE2DB25FX7S2
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on August 26, 2025, valued at $18,488.12. The delivery order, which carries no set-aside designation, is for Trikafta 100-50-75 mg/150 mg tablets, a prescription medication used in the treatment of cystic fibrosis. The order is scheduled for completion by August 27, 2025, with performance taking...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a Firm Fixed Price delivery order contract from the Defense Logistics Agency (DLA) valued at $74,107.32. The contract, which is not associated with a set-aside designation, covers the delivery of Trikafta, a specialty pharmaceutical medication, to support the medical supply needs of military healthcare facilities. This delivery order is issued under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $111,757.17 by the Defense Logistics Agency (DLA) on September 17, 2025. The contract, which has no set-aside designation, calls for the delivery of Trikafta 100-50-75 mg/150 mg tablets in quantities of 84 units. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency (DLA) for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The award, issued on July 26, 2025, with an ultimate completion date of July 28, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $36,976.24 by the Defense Logistics Agency (DLA) on July 31, 2025, with an ultimate completion date of August 1, 2025. The delivery order, issued under a firm fixed-price contract structure with no set-aside designation, covers the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). Performance will occur at the contractor's...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. This delivery order is part of a larger indefinite delivery contract (#4600082013) with DMS Pharmaceutical Group valued up to $4,999,999 for the supply of a broad range of pharmaceutical items to military health facilities globally. The delivery order is for the drug Trikafta, used to treat...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $18,526.83, is to provide the pharmaceutical product Trikafta, a specialty medication used to treat cystic fibrosis. The order has an ultimate completion date of November 20, 2024. DMS Pharmaceutical Group is a key supplier in the DLA's pharmaceutical supply chain,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency on August 5, 2025. The delivery order, which expires August 6, 2025, is for Trikafta 100-50-75 mg/150 mg pharmaceutical products. This award was issued without a set-aside designation and represents a single delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency on July 28, 2025, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The order, which carries an ultimate completion date of July 29, 2025, represents a standard pharmaceutical supply transaction without set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $18,488.12 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg, a cystic fibrosis treatment medication. The delivery order, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a targeted pharmaceutical procurement without set-aside designation. DMS Pharmaceutical Group...
- SPE2DB20D9354Indefinite Delivery Contract
- SPE2DB20D9354-SPE2DB25FX7S2Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency (DLA) on May 6, 2025. The delivery order, which represents a single issuance under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA, covers the supply of Trikafta (a prescription medication used to treat cystic fibrosis) in the 100-50-75 mg/150 mg formulation with 84 tablets. The contract carries no set-aside designation, and the ultimate completion date is May 7, 2025, with performance to be completed at the vendor's facility in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's significant single-award IDC with the DLA valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide. The company's established federal contract portfolio demonstrates consistent success in supplying branded and generic prescription drugs, biologics, and medical consumables to military health systems, positioning it as a key supplier within the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.5k | 5/6/25 |